Please login to the form below

Not currently logged in
Email:
Password:

ALGS

This page shows the latest ALGS news and features for those working in and with pharma, biotech and healthcare.

Silver lining as Shire rare disease programme hits a setback

Silver lining as Shire rare disease programme hits a setback

Alagille syndrome candidate fails to meet phase II targets. Shire suffered a setback in its rare disease pipeline after a candidate for the genetic disease Alagille syndrome (ALGS) failed its objectives ... ALGS is mainly caused by mutation or deletion

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

Whitepaper: Closing the gap with compelling healthcare communications
Want to learn how to close the distance between a person’s current health and their healthiest possible self?...
Healing the Healers
Because if we do not heal the healers, who is going to heal us?...
The (inevitable) digital transformation of Medical Affairs
It’s not a question of ‘if,’ it’s a question of ‘when.’...